首页> 外文期刊>International journal of clinical practice >Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer.
【24h】

Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer.

机译:甲状腺癌评论3:髓样和未分化甲状腺癌的治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

This is the last of the three review articles dealing with thyroid cancer. Over 90% of thyroid cancer is of the differentiated type associated with a very good 10-year disease-free survival rate. In contrast, the rare forms of thyroid cancer which comprise medullary thyroid cancer arising from parafollicluar C cells, Hurthle cell carcinoma, anaplastic carcinoma, thyroid lymphoma and squamous cell carcinoma are typically associated with a poorer survival rate. Management is based upon small retrospective cohort studies.
机译:这是有关甲状腺癌的三篇评论文章中的最后一篇。超过90%的甲状腺癌属于分化型,具有非常好的10年无病生存率。相反,甲状腺癌的罕见形式通常包括较差的存活率,这些甲状腺癌包括由副叶C细胞引起的甲状腺髓样癌,Hurthle细胞癌,间变性癌,甲状腺淋巴瘤和鳞状细胞癌。管理基于小型回顾性队列研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号